TANGO THERAPEUTICS INC
NASDAQ: TNGX (Tango Therapeutics, Inc.)
Last update: 20 hours ago30.94
1.12 (3.76%)
| Previous Close | 29.82 |
| Open | 29.55 |
| Volume | 9,962,709 |
| Avg. Volume (3M) | 3,661,998 |
| Market Cap | 5,037,485,568 |
| Price / Sales | 48.38 |
| Price / Book | 8.18 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2026 |
| Operating Margin (TTM) | -788.76% |
| Diluted EPS (TTM) | -1.20 |
| Quarterly Revenue Growth (YOY) | -16.70% |
| Total Debt/Equity (MRQ) | 22.16% |
| Current Ratio (MRQ) | 6.26 |
| Operating Cash Flow (TTM) | -135.34 M |
| Levered Free Cash Flow (TTM) | -67.25 M |
| Return on Assets (TTM) | -26.79% |
| Return on Equity (TTM) | -61.35% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Tango Therapeutics, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | -3.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 2.0 |
| Average | -0.90 |
|
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 12.59% |
| % Held by Institutions | 97.41% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CRYSTAL ADAM | - | 23.10 | -27,000 | -623,700 |
| Aggregate Net Quantity | -27,000 | |||
| Aggregate Net Value ($) | -623,700 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 23.10 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| CRYSTAL ADAM | Officer | 01 Jun 2026 | Automatic sell (-) | 27,000 | 23.10 | 623,700 |
| CRYSTAL ADAM | Officer | 01 Jun 2026 | Option execute | 27,000 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |